| Hdfc Pharma And Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 27-04-2026 | ||||||
| NAV | ₹18.27(R) | +2.31% | ₹18.84(D) | +2.33% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 12.86% | -% | -% | -% | -% |
| Direct | 14.2% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 6.53% | 23.67% | 12.57% | 14.52% | 8.22% | |
| SIP (XIRR) | Regular | 14.48% | -% | -% | -% | -% |
| Direct | 15.81% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/12/2025 | 1976 Cr | ||||
NAV Date: 27-04-2026
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| HDFC Pharma and Healthcare Fund - IDCW Option | 18.27 |
0.4100
|
2.3100%
|
| HDFC Pharma and Healthcare Fund - Growth Option | 18.27 |
0.4100
|
2.3100%
|
| HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan | 18.84 |
0.4300
|
2.3300%
|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | 18.84 |
0.4300
|
2.3300%
|
Review Date: 27-04-2026
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 6.26 | 2.69 |
5.42
|
2.60 | 7.15 | 5 | 16 | Good |
| 3M Return % | 11.11 | 6.59 |
8.12
|
4.25 | 11.19 | 2 | 16 | Very Good |
| 6M Return % | 5.68 | 4.11 |
0.40
|
-2.94 | 5.68 | 1 | 16 | Very Good |
| 1Y Return % | 12.86 | 6.53 |
6.10
|
1.55 | 12.86 | 1 | 15 | Very Good |
| 1Y SIP Return % | 14.48 |
5.47
|
-12.79 | 14.48 | 1 | 15 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | 6.37 | 2.69 | 5.54 | 2.75 | 7.29 | 5 | 16 | Good |
| 3M Return % | 11.43 | 6.59 | 8.48 | 4.58 | 11.59 | 3 | 16 | Very Good |
| 6M Return % | 6.28 | 4.11 | 1.08 | -2.08 | 6.28 | 1 | 16 | Very Good |
| 1Y Return % | 14.20 | 6.53 | 7.52 | 3.04 | 14.20 | 1 | 15 | Very Good |
| 1Y SIP Return % | 15.81 | 6.88 | -11.58 | 15.81 | 1 | 15 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Hdfc Pharma And Healthcare Fund NAV Regular Growth | Hdfc Pharma And Healthcare Fund NAV Direct Growth |
|---|---|---|
| 27-04-2026 | 18.267 | 18.839 |
| 24-04-2026 | 17.854 | 18.41 |
| 23-04-2026 | 18.028 | 18.589 |
| 22-04-2026 | 17.895 | 18.452 |
| 21-04-2026 | 17.823 | 18.377 |
| 20-04-2026 | 17.811 | 18.364 |
| 17-04-2026 | 17.812 | 18.363 |
| 16-04-2026 | 17.743 | 18.292 |
| 15-04-2026 | 17.731 | 18.279 |
| 13-04-2026 | 17.414 | 17.951 |
| 10-04-2026 | 17.502 | 18.04 |
| 09-04-2026 | 17.386 | 17.92 |
| 08-04-2026 | 17.222 | 17.75 |
| 07-04-2026 | 16.92 | 17.439 |
| 06-04-2026 | 16.854 | 17.37 |
| 02-04-2026 | 16.758 | 17.269 |
| 01-04-2026 | 16.931 | 17.446 |
| 30-03-2026 | 16.979 | 17.495 |
| 27-03-2026 | 17.191 | 17.711 |
| Fund Launch Date: 04/Oct/2023 |
| Fund Category: Pharma Fund |
| Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. |
| Fund Description: An open-ended equity scheme investing in Pharma and healthcare companies |
| Fund Benchmark: BSE Healthcare Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.